Dow Development Laboratories specialises in the formulation, development, and manufacturing of semi-solid and liquid drug products, catering to the pharmaceutical industry. The company provides a comprehensive suite of services including formulation and method development, GMP manufacture, fill and release, packaging, labeling and distribution, as well as ICH stability studies to expedite programmes towards regulatory approval. Dow Development Laboratories operates under the auspices of its parent company, Symbio, which offers global clinical trial management.

Services include:
- 505(b)(2)
- Accelerated Stability Studies
- Analytical Services
- Animal Health
- Clinical Supply Management
- Chemistry (CMC)
- Manufacturing
- Contract Development and Manufacturing (CDMO)
- Distribution
- Clinical Trials
- Dosage Form Development
- Drug Development
- Process Development
- Formulation Development
- In Vitro Testing
- Creams & Ointments
- Dose Form
- Non-Sterile
- Gels
- Generics
- Liquids
- Semisolids
- Solutions & Suspensions
- Preformulation
- R&D Services
- Stability Studies
- Regulatory Services
- Clinical Dose
- Clinical Packaging

Dow Development Laboratories is committed to advancing pharmaceutical innovations and supports clients throughout the drug development process. For more information, please visit dowdevelopmentlabs.com.